Morales, Anecita .
HRN: 29-11-72 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/08/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
06/08/2026
06/15/2026
IV
600mg
Q6
Cellulitis
Checking Initial Appropriateness
06/08/2026
CEFTRIAXONE 1G (VIAL)
06/08/2026
06/15/2026
IV
2g
Od
Cuti
Checking Initial Appropriateness
06/12/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
06/12/2026
06/19/2026
IV
2.25g
Q8h
CELLULITIS
Checking Initial Appropriateness
06/12/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
06/12/2026
06/19/2026
IV
600mg
Q6h
Cellulitis
Checking Initial Appropriateness
06/13/2026
MUPIROCIN 2%, 15G (TUBE)
06/13/2026
06/19/2026
TOPICAL
Apply Thinly On Affected Area
BID
Cellulitis, Right Leg
Checking Initial Appropriateness
06/13/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/13/2026
06/19/2026
IV
500mg
Q8h
Spontaneous Bacterial Peritonitis
Checking Initial Appropriateness
06/21/2026
OXACILLIN 500MG (VIAL)
06/21/2026
06/21/2026
IV
2g
Q4H
Cellulitid
Checking Initial Appropriateness
06/23/2026
MUPIROCIN 2%, 15G (TUBE)
06/23/2026
06/29/2026
TOPICAL
2%
Bid
Cellulitis
Checking Initial Appropriateness